Method of preparing an undifferentiated cell
AssigneeGhazi Jaswinder Dhoot
InventorIlham Saleh Abuljadayel
Life of this patent
Estimating the term…
Abstract
A method of preparing an undifferentiated cell is described. The method comprises contacting a more committed cell with an agent that causes the more committed cell to retrodifferentiate into an undifferentiated cell.
Claims46
A method of preparing an undifferentiated cell, the method comprising contacting a more committed cell with an agent that causes the more committed cell to retrodifferentiate into an undifferentiated cell.
A method according to any one of the preceding claims wherein the more committed cell is capable of retrodifferentiating into a CD34+ undifferentiated cell.
A method according to any one of the preceding claims wherein the more committed cell is capable of retrodifferentiating into a lymphohaematopoietic progenitor cell.
A method according to any one of the preceding claims wherein the more committed cell is capable of retrodifferentiating into a pluripotent stem cell.
A method according to any one of the preceding claims wherein the undifferentiated cell is an MHC Class I+ and/or an MHC Class II+ cell.
A method according to any one of the preceding claims wherein the undifferentiated cell comprises a stem cell antigen.
A method according to any one of the preceding claims wherein the undifferentiated cell is a CD34+ undifferentiated cell.
A method according to any one of the preceding claims wherein the undifferentiated cell is a lymphohaematopoietic progenitor cell.
A method according to any one of the preceding claims wherein the undifferentiated cell is a pluripotent stem cell.
A method according to any one of the preceding claims wherein the more committed cell is an MHC Class I+ and/or an MHC Class II+ cell.
A method according to any one of the preceding claims wherein the agent acts extracelluarly of the more committed cell.
A method according to any one of the preceding claims wherein the more committed cell comprises a receptor that is operably engageable by the agent and wherein the agent operably engages the receptor.
A method according to any one of the preceding claims wherein the agent modulates MHC gene expression, preferably wherein the agent modulates MHC Class I+ and/or MHC Class II+ expression.
A method according to any one of the preceding claims wherein the agent is used in conjunction with a biological response modifier.
A method according to any one of the preceding claims wherein the more committed cell is a differentiated cell.
A method according to any one of the preceding claims wherein the undifferentiated cell is committed to a recommitted cell.
A method according to any one of the preceding claims wherein the method is an in vitro method.
A more committed cell having attached thereto an agent that can cause the more committed cell to retrodifferentiate into an undifferentiated cell.
A CD19+ and CD3+ cell.
A method of preparing an undifferentiated cell from a more committed cell substantially as hereinbefore described.
An undifferentiated cell prepared from a more committed cell substantially as hereinbefore described.
A recommitted cell prepared from an undifferentiated cell which has been prepared from a more committed cell substantially as hereinbefore described.
Dependencies are inferred from the claim text.